
Public Affairs – fostering knowledge transfer between industry and public stakeholders
Our public affairs team aspires to be a leader in responsibility and transparency in the public policy process regarding medicinal cannabis and the cannabis legalization for adult-use.
We are committed to open and transparent discussions that advance the discourse on facts, create a safe and better future for our partners, customers and patients in order to promote trust in the European cannabis industry.
We are proud member of key associations within the cannabis industry, furthering our commitment to excellence and collaboration. As a board member (“Vorstandsmitglied”) of the BPC (Federal Association of Pharmaceutical Cannabinoid Companies), we actively contribute to shaping the voice of pharmaceutical cannabinoid companies in Germany. Furthermore, as a supporting member (“Fördermitglied”) of the VCA (Association of Cannabis Supplying Pharmacies e.V.), we are at the forefront of ensuring quality cannabis care through pharmacies. These partnerships underscore our dedication to leading the industry forward with integrity and expertise.
In addition to our focus on ethical business practices, we prioritize compliance with all relevant laws and regulations in the industry, including registering our lobbying activities and working in accordance with state code of conduct.
Find our latest publications and political letters here.
Press
notices
Keep up to date with the latest news from Cansativa – from product launches and successes to our latest positions on current developments.
25. September 2024
Thanks to Cansativa: Cookies products are now available in Germany!
"Yes, we can Cannabizz" – Berner is coming to Germany on November 14th.
11. June 2024
Cansativa and Cookies team up to bring Cookies products into the German medical cannabis market.
Cansativa Group will exclusively distribute Cookies-branded medical cannabis products across Germany starting 1st of August 2024
30. October 2023
Cansativa and Cronos Group Inc. launch leading medical cannabis brand PEACE NATURALS® in Germany
Cansativa will import, distribute, and market Cronos brand PEACE NATURALS® Frankfurt am Main, 30th of October 2023
Company presentation
to download

CP 2025
PDF-File (3 MB)
Read
our cannabis
Briefing.
Stay up to date on the latest developments in medical cannabis and the legalization process for adult recreational use.
6. November 2025
Fewer Opioids, More Perspectives – What Current Studies on Medical Cannabis Reveal
Opioids are effective – and risky. They relieve pain, but can also lead to dependence, respiratory depression, and in the worst case, death. This is…
23. October 2025
Cansativa Expert Dialogue – Behind the Scenes of Medical Cannabis Supply
Anyone ensuring that patients across Germany receive their medical cannabis on time works in what is likely the country’s largest medical cannabis…
9. October 2025
Medical Cannabis on Its Way to Parliament – What the Cabinet Approval Means Now
Yesterday, the German federal cabinet approved the draft bill to amend the Medical Cannabis Act (MedCanG) – despite continued criticism from industry…
25. September 2025
The Cannabis Act Under Review: What Can We Expect?
Soon, the first results of the evaluation of the Cannabis Act will be published. What developments they will show remains open. Until then, current…
11. September 2025
Switzerland Moves Forward with Legalization
Switzerland is making noticeable progress on cannabis legalization. In one of our earlier editions, we reported that a government report was expected…
28. August 2025
New GACP Guidelines Bring Stricter Requirements for Medical Cannabis
In this issue, we dive a little deeper into regulatory specifics: the GACP guidelines. For many in the industry, they are a familiar framework; for…
8. August 2025
On a personal note: Our Nomination for the Pioneer Award 2025
Today, we want to use our newsletter for the first time to share a very personal message: We have been nominated for the Pioneer Award 2025 in the…
24. July 2025
Medical Cannabis Under Scrutiny? The new draft bill from the German Health Ministry
The current draft bill to amend the Medical Cannabis Act (MedCanG) has sparked debate within the cannabis industry. What exactly does this first step…
10. July 2025
Medical Cannabis in Europe: Latest Developments and Germany’s Role in 2025
Medical cannabis is creating waves across Europe—from regulatory advances to controversial setbacks. We have summarized the latest developments from…
27. June 2025
Cansativa Expert Dialogue: Antonia Menzel (BPC) on the Role of Lobbying in the Cannabis Industry
In today's edition of the Cannabis Briefing, we speak with Antonia Menzel, who has been the Chairwoman of the Federal Association of Pharmaceutical…
Position papers
& Publications
Our position papers address many of the most important issues in our business area. They transparently explain our company position and current assessment on specific topics
Known from
Explore Our Cannabis Briefing
Stay ahead with the latest insights in medical cannabis, political decisions, industry news, and research advances.
Stay informed!
Our newsletter is designed to keep you informed and ahead in the rapidly evolving world of medical cannabis. The Cannabis Briefing is your essential resource for the latest research findings, regulatory updates, market trends, and advocacy efforts shaping the future of cannabis.